Detalles de la búsqueda
1.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res;
24(1): 229, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749551
2.
Improving lung health in low-income and middle-income countries: from challenges to solutions.
Lancet;
397(10277): 928-940, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631128
3.
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
Respirology;
27(12): 1034-1044, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970518
4.
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
203(1): 24-36, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146552
5.
COVID-19 and COPD: lessons beyond the pandemic.
Am J Physiol Lung Cell Mol Physiol;
321(5): L978-L982, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34585618
6.
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
N Engl J Med;
378(18): 1671-1680, 2018 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29668352
7.
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma.
Eur Respir J;
58(4)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266940
8.
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Respir Res;
22(1): 130, 2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910578
9.
Reducing the hidden burden of severe asthma: recognition and referrals from primary practice.
J Asthma;
58(7): 849-854, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347748
10.
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
Am J Respir Crit Care Med;
202(9): 1237-1243, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584168
11.
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
201(12): 1508-1516, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162970
12.
The effect of exacerbation history on outcomes in the IMPACT trial.
Eur Respir J;
55(5)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299860
13.
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial.
Respir Res;
21(1): 177, 2020 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646424
14.
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
Respir Res;
21(1): 139, 2020 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32503599
15.
Bronchodilator Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease: Time to Stop Chasing Shadows.
Am J Respir Crit Care Med;
209(4): 349-351, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190497
16.
Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation.
Am J Respir Crit Care Med;
199(10): 1195-1204, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592902
17.
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.
Am J Respir Crit Care Med;
209(8): 928-937, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38358788
18.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Eur Respir J;
53(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846476
19.
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
Respir Res;
20(1): 159, 2019 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319851
20.
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res;
25(1): 152, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561735